Clinical trials

  • Ponatinib for Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL)
  • Vedolizumab for Crohn's disease | Moderately to severely active Crohn's disease
  • AZD0305 for Multiple myeloma
  • COLCHICINE for Lower extremity artery disease
  • HYDROXYCARBAMIDE for Acute myeloid leukaemia (AML) - newly diagnosed
  • BHV-7000 for Refractory focal onset epilepsy
  • Cannabis sativa flower (Δ9-THC and other cannabinoids) for Diabetic peripheral neuropathic pain
  • TRASTUZUMAB DERUXTECAN for Non-small cell lung cancer
  • Alpelisib for PIK3CA-related overgrowth spectrum (PROS)
  • ISATUXIMAB for Relapsed/refractory multiple myeloma
  • LIDOCAINE HYDROCHLORIDE for Implantation of cardiac implantable electronic device (CIED)
  • FYB202 for Chronic inflammatory diseases | Psoriasis | Crohn's disease | Psoriatic arthropathy